Chief Physician: Rs Treatment for Infants a Success – but the Worst Is yet to Come
3 Articles
3 Articles
Since last fall, infants have been offered preventive treatment with antibodies against the RS virus. Healthcare professionals are already noticing positive effects with fewer sick children. However, the Public Health Agency wants to wait a bit before establishing anything for sure – there is still a large part of the illness season left.
The Respiratory Syncytial Virus (RSV) is a worldwide widespread pathogen of acute respiratory diseases. According to the Robert Koch institute, it is currently on the rise in Germany.
The vaccination campaign against the Respiratory Syncicial Virus (RSV), the main cause of bronchiolitis in infants and young children, began.The application of this vaccine during pregnancy allows the prevention of serious forms of the disease during the first months of life.The antibodies generated by the vaccination are transmitted to the baby through placenta and breastfeeding, providing protection to newborns from birth. The VSR vaccine is a…
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
